Cytosolic prostaglandin e synthase: Expression patterns in control and alzheimer's disease brains

11Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Anti-inflammatory drugs reduce the risk of Alzheimer's disease but fail to slow its progression. Studying the expression of prostaglandin E2 synthases downstream of cyclooxygenase-2 is important. Here, the expression patterns of cytosolic prostaglandin E2 synthases, an immediate prostaglandin E2 source was investigated. Sections taken from the middle frontal gyrus of brains of 10 patients with Alzheimer's and 5 age-matched controls were examined by immunostaining for the presence of the synthases. Immunofluorescence analysis of control brains showed that cytosolic prostaglandin E2 synthases co-localize with microglia, neurons, and endothelium markers, but not with astrocytes or smooth muscle cells. Immunohistochemical staining for the synthases was positive in the pyramidal neurons of controls but barely detectable in the brain of Alzheimer's patients. These findings revealed that cytosolic prostaglandin E2 synthases is found in microglia, neurons, and endothelium of control human middle frontal gyrus and that its levels decrease in pyramidal cells of Alzheimer's disease brains. © 2009 Sage Publications.

Cite

CITATION STYLE

APA

Chaudhry, U. A., & Dore, S. (2009). Cytosolic prostaglandin e synthase: Expression patterns in control and alzheimer’s disease brains. American Journal of Alzheimer’s Disease and Other Dementias, 24(1), 46–51. https://doi.org/10.1177/1533317508323655

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free